πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 10 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12270050

Human T cell derived from T cell-derived induced pluripotent stem cell and methods of maki

Regents of the University of Minnesota Β· Granted Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12257266

Stem cell-derived exosomes for the treatment of corneal scarring

The Regents of the University of California Β· Granted Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11857575

Mesenchymal stem cell-derived exosomes and their uses

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10160954

Engineered physical alignment of stem cell-derived cardiomyocytes

The Regents of the University of California Β· Granted Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9783616

Regulating transplant rejection of donor and embryonic stem cell-derived tissues and organ

UNIVERSITY OF CONNECTICUT Β· Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9045731

Compositions and methods for improving the functional efficacy of stem cell-derived cardio

The Regents of the University of California Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8822218

Method of generating natural killer cells and dendritic cells from human embryonic stem ce

Stem Cell & Regenerative Medicine International Β· Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8058403

Antibodies to stromal cell-derived factor-1 polypeptides

Five Prime Therapeutics, Inc. Β· Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7776564

Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and method

Five Prime Therapeutics, Inc. Β· Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7709625

Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes fo

The Board of Regents of the University of Texas Β· Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted